Clinical Trials Directory

Trials / Completed

CompletedNCT03299582

PREventing CHemotherapy Induced Neuropathy (PreChIN)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

The project is designed to study the use of localized hypothermia alone, or with compression to the limbs during chemotherapy infusion for the prevention of chemotherapy induced peripheral neuropathy (CIPN). As a pilot study, safety, tolerability and early clinical activity will be studied. The study will be conducted on healthy volunteers and cancer patients receiving taxane chemotherapy.

Detailed description

Localized limb hypothermia during chemotherapeutic infusion may prevent a common side effect of chemotherapy: chemotherapy-induced peripheral neuropathy (CIPN). There are no reliable methods for the prevention or the treatment of CIPN. On the basis of the dose-related pathophysiology of CIPN, the investigators hypothesize that reducing the delivery of the toxic chemotherapeutic agents to the peripheral nerves by reducing blood flow through hypothermia may reduce the occurrence of CIPN. The proposed potential treatment method would aim to reduce the development of CIPN. This project comprises of a healthy subject trial to investigate the best tolerated temperature which will be used in cancer subject trial to investigate the safety and tolerability of hypothermia or cryocompression (hypothermia with pressure) in the prevention of CIPN in cancer subjects undergoing taxane-based chemotherapy.

Conditions

Interventions

TypeNameDescription
DEVICEHypothermiaHealthy subjects will undergo 3 hours of hypothermia at various temperature levels.Cancer subjects will undergo 4 hours of hypothermia during every cycle of chemotherapy.
DEVICECryocompressionHealthy subjects will undergo 3 hours of cryocompression. Cancer subjects will undergo a minimum duration of 2 hours and a maximum duration of up to 4 hours of cryocompression during every cycle of chemotherapy.

Timeline

Start date
2013-06-13
Primary completion
2016-11-03
Completion
2017-02-15
First posted
2017-10-03
Last updated
2017-10-03

Source: ClinicalTrials.gov record NCT03299582. Inclusion in this directory is not an endorsement.